Form 4 Tracker
Amneal Pharmaceuticals, Inc.
AMRX

23 insider filings · Latest: May 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 11, 2026May 12 8:10 PMDeborah M. AutorDirector
Sale
34,819$12.94$450.6K93,660(D)

View →

May 11, 2026May 11 10:56 PMDEBORAH AUTOR
Proposed Sale
34,819$12.94$450.4K

View →

Nov 17, 2025Nov 17 8:06 PMNark Ted C
Proposed Sale
50,000$11.83$591.3K

View →

Nov 12, 2025Nov 12 10:12 PMNIKITA SHAH
Proposed Sale
131,856$11.92$1.6M

View →

Aug 27, 2025Aug 27 7:04 PMKiely John
Proposed Sale
32,000$9.18$293.8K

View →

Aug 22, 2025Aug 22 8:03 PMShah Nikita
Proposed Sale
36,796$9.70$356.9K

View →

Aug 22, 2025Aug 22 4:18 PMShah Nikita
Proposed Sale
84,036$9.75$818.9K

View →

Aug 20, 2025Aug 20 8:16 PMBOYER ANDREW S
Proposed Sale
175,000$9.36$1.6M

View →

Aug 20, 2025Aug 20 2:26 PMBOYER ANDREW S
Proposed Sale
104,244$9.30$969.5K

View →

Aug 15, 2025Aug 15 3:14 PMKonidaris Tasos
Proposed Sale
219,159$9.39$2.1M

View →

Aug 14, 2025Aug 14 8:10 PMShah Nikita
Proposed Sale
71,694$9.25$663.1K

View →

Aug 13, 2025Aug 13 7:08 PMKonidaris Tasos
Proposed Sale
169,206$9.27$1.6M

View →

Aug 13, 2025Aug 13 2:41 PMKonidaris Tasos
Proposed Sale
111,635$9.02$1.0M

View →

Aug 12, 2025Aug 12 8:06 PMBOYER ANDREW S
Proposed Sale
33,436$9.09$304.1K

View →

Aug 12, 2025Aug 12 8:04 PMDaly Jason B.
Proposed Sale
22,000$9.00$198.0K

View →

Aug 12, 2025Aug 12 7:09 PMShah Nikita
Proposed Sale
50,000$9.06$453.0K

View →

May 16, 2025May 16 8:02 PMShah Nikita
Proposed Sale
49,140$7.50$368.6K

View →

May 12, 2025May 12 8:07 PMKiely John
Proposed Sale
50,000$7.57$378.5K

View →

May 2, 2025May 2 8:38 PMGautam Patel
Proposed Sale
160,000$7.74$1.2M

View →

Mar 14, 2025Mar 14 11:32 PMPatel Tushar Bhikhubhai
Proposed Sale
5,000,000$8.75$43.8M

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 4, 2026Mar 5 9:51 PMPatel Chirag K.Director, President & Co-CEO
Option Exercise
92,593185,185(D)

View →

Mar 3, 2026Mar 5 9:51 PMPatel Chirag K.Director, President & Co-CEO
Option Exercise
793,8750(D)

View →

Mar 4, 2026Mar 5 9:32 PMJason B. DalyEVP, Chief Legal Officer
Option Exercise
35,88071,760(D)

View →

Mar 3, 2026Mar 5 9:32 PMJason B. DalyEVP, Chief Legal Officer
Option Exercise
390,9390(D)

View →

Mar 4, 2026Mar 5 9:31 PMTasos KonidarisExecutive Vice President & CFO
Option Exercise
49,98287,963(D)

View →

Mar 3, 2026Mar 5 9:31 PMTasos KonidarisExecutive Vice President & CFO
Option Exercise
589,8830(D)

View →

Mar 4, 2026Mar 5 9:31 PMAndrew S BoyerExecutive Vice President
Option Exercise
38,19576,389(D)

View →

Mar 3, 2026Mar 5 9:31 PMAndrew S BoyerExecutive Vice President
Option Exercise
510,7580(D)

View →

Mar 4, 2026Mar 5 9:30 PMNikita ShahExecutive Vice President
Option Exercise
35,88071,760(D)

View →

Mar 3, 2026Mar 5 9:30 PMNikita ShahExecutive Vice President
Option Exercise
472,6190(D)

View →

Mar 2, 2026Mar 3 9:29 PMPatel ChintuDirector, Co-CEO
Grant/Award
544,663354,031(D)

View →

Mar 2, 2026Mar 3 9:29 PMPatel Chirag K.Director, President & Co-CEO
Grant/Award
544,663354,031(D)

View →

Mar 2, 2026Mar 3 9:28 PMNikita ShahExecutive Vice President
Grant/Award
130,71865,359(D)

View →

Mar 2, 2026Mar 3 9:28 PMTasos KonidarisExecutive Vice President & CFO
Grant/Award
145,24472,622(D)

View →

Mar 2, 2026Mar 3 9:27 PMJason B. DalyEVP, Chief Legal Officer
Grant/Award
130,71865,359(D)

View →

Mar 2, 2026Mar 3 9:26 PMAndrew S BoyerExecutive Vice President
Grant/Award
130,71865,359(D)

View →

← Previous

Page 2 of 2